Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time

OBJECTIVES: We aimed to evaluate the effects of methotrexate (MTX) comedication added to biological disease-modifying antirheumatic drugs (bDMARD) on disease activity measures in patients with rheumatoid arthritis (RA) in routine care. METHODS: Patients with RA on treatment with either bDMARDs or co...

Descripción completa

Detalles Bibliográficos
Autores principales: Boone, Niels W., Sepriano, Alexandre, van der Kuy, Paul-Hugo, Janknegt, Rob, Peeters, Ralph, Landewé, Robert B. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347027/
https://www.ncbi.nlm.nih.gov/pubmed/30740244
http://dx.doi.org/10.1136/rmdopen-2018-000836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347027/
https://www.ncbi.nlm.nih.gov/pubmed/30740244
http://dx.doi.org/10.1136/rmdopen-2018-000836

Ejemplares similares